Wisconsin Poison Center, Department of Emergency Medicine, Section of Medical Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.
Indiana Poison Center, Indianapolis, IN, USA.
Clin Toxicol (Phila). 2019 Dec;57(12):1220-1413. doi: 10.1080/15563650.2019.1677022. Epub 2019 Nov 21.
This is the 36 Annual Report of the American Association of Poison Control Centers' (AAPCC) National Poison Data System (NPDS). As of 1 January, 2018, 55 of the nation's poison centers (PCs) uploaded case data automatically to NPDS. The upload interval was 7.72 [6.90, 12.0] (median [25%, 75%]) minutes, creating a near real-time national exposure and information database and surveillance system. We analyzed the case data tabulating specific indices from NPDS. The methodology was similar to that of previous years. Where changes were introduced, the differences are identified. Cases with medical outcomes of death were evaluated by a team of medical and clinical toxicologist reviewers using an ordinal scale of 1-6 to assess the Relative Contribution to Fatality (RCF) of the exposure. In 2018, 2,530,238 closed encounters were logged by NPDS: 2,099,751 human exposures, 57,017 animal exposures, 368,025 information requests, 5,346 human confirmed nonexposures, and 99 animal confirmed nonexposures. United States PCs also made 2,621,242 follow-up calls in 2018. Total encounters showed a 2.96% decline from 2017, while health care facility (HCF) human exposure cases remained nearly steady with a slight decrease of 0.261%. All information requests decreased by 15.5%, medication identification (Drug ID) requests decreased by 30.2%, and human exposure cases decreased by 0.729%. Human exposures with less serious outcomes have decreased 2.33% per year since 2008, while those with more serious outcomes (moderate, major or death) have increased 4.45% per year since 2000.Consistent with the previous year, the top 5 substance classes most frequently involved in all human exposures were analgesics (10.8%), household cleaning substances (7.28%), cosmetics/personal care products (6.53%), sedatives/hypnotics/antipsychotics (5.53%), and antidepressants (5.22%). For cases with more serious outcomes, sedative/hypnotics/antipsychotics exposures were the class that increased most rapidly, by 1,828 cases/year (9.21%/year) over the past 18 years. Over just the past 10 years (for cases with the most serious outcomes) antidepressant exposures increased most rapidly, by 1,887 cases/year (7.02%/year).The top 5 most common exposures in children age 5 years or less were cosmetics/personal care products (12.1%), household cleaning substances (10.7%), analgesics (9.04%), foreign bodies/toys/miscellaneous (6.87%), and topical preparations (4.69%). Drug identification requests comprised 18.2% of all information requests. NPDS documented 3,111 human exposures resulting in death; 2,582 (83.0%) of these were judged as related (RCF of 1-Undoubtedly responsible, 2-Probably responsible, or 3-Contributory). These data support the continued value of PC expertise and need for specialized medical toxicology information to manage more serious exposures. Unintentional and intentional exposures continue to be a significant cause of morbidity and mortality in the US. The near real-time status of NPDS represents a national public health resource to collect and monitor US exposure cases and information requests. The continuing mission of NPDS is to provide a nationwide infrastructure for surveillance for all types of exposures (e.g., foreign body, infectious, venomous, chemical agent, or commercial product), and the identification and tracking of significant public health events. NPDS is a model system for the near real-time surveillance of national and global public health.
这是美国毒物控制中心协会(AAPCC)国家毒物数据系统(NPDS)的第 36 份年度报告。截至 2018 年 1 月 1 日,全国有 55 个毒物中心(PC)自动将病例数据上传到 NPDS。上传间隔为 7.72 [6.90, 12.0](中位数[25%,75%])分钟,创建了一个近乎实时的全国暴露和信息数据库和监测系统。我们分析了 NPDS 中的病例数据,列出了特定指标。该方法与前几年类似。在引入更改的地方,会识别出差异。使用由医学和临床毒理学家组成的团队对有医疗结局的死亡病例进行评估,使用 1-6 的顺序量表评估暴露的相对致死贡献(RCF)。2018 年,NPDS 记录了 2530238 例闭合性接触:2099751 例人体暴露,57017 例动物暴露,368025 例信息请求,5346 例人类确认非暴露,99 例动物确认非暴露。美国毒物中心还在 2018 年拨打了 2621242 个随访电话。总接触量比 2017 年下降了 2.96%,而医疗保健机构(HCF)人体暴露病例基本保持稳定,略有下降 0.261%。所有信息请求下降了 15.5%,药物鉴定(Drug ID)请求下降了 30.2%,人体暴露病例下降了 0.729%。自 2008 年以来,症状较轻的人体暴露病例每年减少 2.33%,而症状较重(中度、重度或死亡)的人体暴露病例每年增加 4.45%。与前一年一样,最常涉及所有人体暴露的前 5 类物质是镇痛药(10.8%)、家用清洁剂(7.28%)、化妆品/个人护理产品(6.53%)、镇静剂/催眠药/抗精神病药(5.53%)和抗抑郁药(5.22%)。对于症状较重的病例,镇静剂/催眠药/抗精神病药的暴露是过去 18 年来增加最快的类别,每年增加 1828 例(9.21%/年)。就在过去 10 年(对于症状最严重的病例),抗抑郁药的暴露增加最快,每年增加 1887 例(7.02%/年)。5 岁及以下儿童最常见的 5 种暴露是化妆品/个人护理产品(12.1%)、家用清洁剂(10.7%)、镇痛药(9.04%)、异物/玩具/杂物(6.87%)和局部制剂(4.69%)。药物鉴定请求占所有信息请求的 18.2%。NPDS 记录了 3111 例导致死亡的人体暴露;其中 2582 例(83.0%)被判断为相关(RCF 为 1-毫无疑问负责,2-可能负责,或 3-有贡献)。这些数据支持毒物中心专业知识的持续价值和对更严重暴露的特殊医疗毒理学信息的需求。意外和故意暴露仍然是美国发病率和死亡率的一个重要原因。NPDS 的近乎实时状态代表了一个国家公共卫生资源,用于收集和监测美国的暴露病例和信息请求。NPDS 的持续使命是为所有类型的暴露(如异物、传染性、有毒、化学剂或商业产品)提供一个全国性基础设施,以及识别和跟踪重大公共卫生事件。NPDS 是一个近乎实时监测国家和全球公共卫生的模型系统。